This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Robert Steyer

Special to

Robert Steyer, who joined in July 2003, has written about the business of science, medicine and health care for the St. Louis Post-Dispatch and the Newark Star-Ledger. He also has been a reporter for Fortune, an editor at CFO Magazine and an assistant business editor at the Tampa Tribune.

He has a B.A. in government from Oberlin College and an M.B.A. from New York University.

Robert Steyer
By This Author:
Page 3 of 148

After Exubera, Uncertainty Reigns

By Robert Steyer

Pfizer's decision to drop inhaled insulin could dim the prospects for competing products.

04:01PM 10/22/07

Hot Art From the Arctic

By Robert Steyer

Inuit prints from northern Canada offer a beautiful -- and affordable -- investment.

09:47AM 10/19/07

Can Good Health Last for Medical IPOs?

By Robert Steyer

The first part of the year was solid for new biotechs and health stocks.

02:20PM 09/11/07

Challenges Persist for Glaxo

By Robert Steyer

Fans say the company is too big to fail, but it's also too big to grow much without developing more hits.

04:43PM 08/22/07

J&J's Risperdal Gets New Uses

By Robert Steyer

The drug is approved by the FDA for younger patients.

04:35PM 08/22/07

Pfizer Finds New CFO

By Robert Steyer

Frank D'Amelio will join the company from Alcatel-Lucent.

11:18AM 08/22/07

FDA Approves Novartis Osteoporosis Drug

By Robert Steyer

Reclast is a once-a-year treatment.

05:19PM 08/20/07

Glaxo Drug Gets Black Box

By Robert Steyer

Avandia will carry a new warning.

05:38PM 08/14/07

Wyeth Whacked on Drug Setbacks

By Robert Steyer

It gets bad news from the FDA and pulls a hepatitis C drug candidate.

01:49PM 08/10/07

One Giant Leap for MannKind

By Robert Steyer

The company will sell $350 million in debt, warrants and stock.

05:48PM 08/09/07

Page 3 of 148

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV


DOW 17,779.78 +1.63 0.01%
S&P 500 2,067.34 +6.11 0.30%
NASDAQ 4,762.2460 +13.85 0.29%

Brokerage Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs